about
A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal MuscleSoluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistanceFuture Perspectives of Personalized Weight Loss Interventions Based on Nutrigenetic, Epigenetic, and Metagenomic Data.β-cell mass in people with type 2 diabetes.Complexity of receptor tyrosine kinase signal processing.An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndromeAMP-activated protein kinase and the regulation of glucose transport.Regulating insulin signaling and beta-cell function through IRS proteins.Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).Nuclear IRS-1 and cancerHyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle.AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia.Effect of short hairpin RNA-mediated adiponectin/Acrp30 down-regulation on insulin signaling and glucose uptake in the 3T3-L1 adipocytes.Gestational Protein Restriction Impairs Glucose Disposal in the Gastrocnemius Muscles of Female Rats.Bovine α-Lactalbumin Hydrolysates (α-LAH) Ameliorate Adipose Insulin Resistance and Inflammation in High-Fat Diet-Fed C57BL/6J Mice.
P2860
Q26747591-0DACB96B-19EC-4E23-8703-D7150AC34A63Q28388993-67205A68-7954-44BD-89C0-CE02932D917FQ31056421-129B2312-CE58-4288-9453-A15DB05C37D3Q33558395-1FAF2462-41BE-4D4F-B9F0-85272C08D743Q34361161-96C57443-C102-4B23-9E56-355A0ED3243BQ35213260-A87D538E-0538-48B2-B55D-EC667E281082Q36528251-AF5FC059-FC9E-425E-9D6F-55657002F16EQ36602630-324E0FA9-6810-4D2E-941A-F51017543D99Q36756469-B7DDCAF4-036E-43B8-850F-B8843815B831Q37407344-EDF1F002-DDF5-48BE-98DC-ABD45DA3271BQ37997745-7F1028FB-C951-40E5-BF94-C3DC4C435B87Q38905205-6AD87CC7-A1F5-462C-80F6-A03C071C7B58Q39652396-76FD409F-C966-4340-ADDC-4BC868F51142Q42457601-E782012B-BC1C-49DF-A474-53A7204E7400Q47821534-DDF96EF4-563D-40EE-B3F8-AEB081922DB8Q52688599-DC657B67-52E9-445F-8B3C-C83F7EBFA2BB
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
IRS-1 regulation in health and disease.
@ast
IRS-1 regulation in health and disease.
@en
type
label
IRS-1 regulation in health and disease.
@ast
IRS-1 regulation in health and disease.
@en
prefLabel
IRS-1 regulation in health and disease.
@ast
IRS-1 regulation in health and disease.
@en
P1433
P1476
IRS-1 regulation in health and disease
@en
P2093
Carsten Schmitz-Peiffer
Jonathan P Whitehead
P304
P356
10.1080/1521654031000138569
P577
2003-07-01T00:00:00Z